Hearing News Watch

Featured image for “IHS 2024 Event Highlights: Networking, Education, and Industry Insights Take Center Stage”
Sep. 26, 2024

IHS 2024 Event Highlights: Networking, Education, and Industry Insights Take Center Stage

HHTM
FARMINGTON HILLS, MICHIGAN – Attendees of the International Hearing Society (IHS) 2024 Conference & Expo, held in Louisville, Kentucky, embraced the conference theme of “Take the Lead” in record numbers, with attendance increasing by 20% and sponsor engagement rising by 25% compared to last year. The Kentucky Derby-themed event provided participants the opportunity to earn up to 14.5 continuing education
Featured image for “EUHA Announces New Executive Committee and Council of Honour Members”
Sep. 26, 2024

EUHA Announces New Executive Committee and Council of Honour Members

HHTM
The EUHA held its General Meeting on 25 September 2024, during which members of the EUHA Executive Committee, Auditing Committee, and Council of Honour were elected. The new leadership is now ready to move forward with their term. Beate Gromke was re-elected as President, marking her third term. Eva Keil-Becker will continue as Vice President, and Peter Möckel remains both
Featured image for “EUHA2024: EUHA-Live Area Set to Showcase Industry Innovations”
Sep. 23, 2024

EUHA2024: EUHA-Live Area Set to Showcase Industry Innovations

HHTM
The European Union of Hearing Aid Acousticians (EUHA) and the German Hearing Instruments Industry Association (BVHI) continue to advance the International Congress of Hearing Aid Acousticians. A newly introduced feature, the EUHA-Live Area, will include a stage and a designated meeting and networking space, enhancing the connection between the Congress and the Industry Exhibition through spatial arrangement and events. Within
Featured image for “Sensorion Announces New Positive Clinical Data Across Its Gene Therapy and Small Molecule Programs at WCA Conference”
Sep. 20, 2024

Sensorion Announces New Positive Clinical Data Across Its Gene Therapy and Small Molecule Programs at WCA Conference

HHTM
Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat, and prevent hearing loss disorders, announced new positive medical data from its clinical programs, SENS-501 and SENS-401, during a symposium at the 36th World Congress of Audiology (WCA) in Paris, held at CNIT, La Défense, France. The company presented data from
Featured image for “Lineage Presents Promising Preclinical Results for Auditory Neuronal Cell Therapy”
Sep. 19, 2024

Lineage Presents Promising Preclinical Results for Auditory Neuronal Cell Therapy

HHTM
CARLSBAD, CALIFORNIA — Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported that preclinical results with ReSonance (ANP1), the company’s auditory neuronal cell transplant for the treatment of hearing loss, were presented at the 59th Annual Inner Ear Biology Workshop by Ofer Wiser, Ph.D. Senior Scientist, Technological Innovation
Featured image for “Starkey’s Achin Bhowmik, Ph.D., Appointed to U.S. FDA Digital Health Advisory Committee”
Sep. 18, 2024

Starkey’s Achin Bhowmik, Ph.D., Appointed to U.S. FDA Digital Health Advisory Committee

HHTM
EDEN PRAIRIE, MINNESOTA — Starkey has announced that its Chief Technology Officer, Achin Bhowmik, Ph.D., has been appointed as an Industry Representative for the U.S. FDA Digital Health Advisory Committee. The Digital Health Advisory Committee provides expert guidance to the FDA on matters related to the development and regulation of digital health technologies. Dr. Bhowmik’s selection reflects Starkey’s ongoing commitment
Featured image for “Academy of Doctors of Audiology Launches Audiology 2050 Initiative”
Sep. 16, 2024

Academy of Doctors of Audiology Launches Audiology 2050 Initiative

HHTM
FRANKFURT, KENTUCKY – During the AuDacity 2024 Conference, the Academy of Doctors of Audiology (ADA) announced the launch of the Audiology 2050 Initiative, laying out a bold vision for audiology’s future. With patient well-being at its core, the Audiology 2050 roadmap aims to solidify the role of audiologists as primary care providers for auditory and vestibular conditions, advance professional standards,
Featured image for “Researchers Develop New Model for Predicting Hearing Recovery After Sudden Hearing Loss”
Sep. 14, 2024

Researchers Develop New Model for Predicting Hearing Recovery After Sudden Hearing Loss

HHTM
A new study published in JAMA Otolaryngology introduces a prognostic model aimed at predicting hearing recovery in patients with idiopathic sudden onset sensorineural hearing loss (iSSNHL). This condition, characterized by a rapid, unexplained hearing loss, poses challenges for both patients and healthcare providers. The model aims to provide more clarity in treatment decisions, especially considering the variability in recovery outcomes.
Featured image for “Beltone Earns USA TODAY Top Retailer Title, Kicks Off Hear2End Hunger Food Drive”
Sep. 14, 2024

Beltone Earns USA TODAY Top Retailer Title, Kicks Off Hear2End Hunger Food Drive

HHTM
CHICAGO, ILLINIOS – Beltone announced it has been recognized by USA TODAY as a Top Retailer in Hearing Care for 2024. To mark this achievement, the company is launching its Hear2End Hunger Food Drive, aimed at supporting communities nationwide through its network of locations. The Hear2End Hunger initiative addresses food insecurity, impacting 12.8% of U.S. households, including older adults. Beltone
Featured image for “Apple Introduces OTC Hearing Aid Function for AirPods Pro 2”
Sep. 09, 2024

Apple Introduces OTC Hearing Aid Function for AirPods Pro 2

HHTM
Apple’s announcement today introduced significant new hearing health capabilities to its AirPods Pro 2, marking a major milestone in the company’s ongoing integration of health technology. These features, including a clinical-grade OTC hearing aid function and a clinically validated hearing test, position the AirPods Pro 2 as a potential game-changer in hearing care, especially for individuals with mild to moderate